Cargando…
Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via Sirt1/AMPK signaling
OBJECTIVE(S): Liraglutide, a well-established drug for treating diabetes mellitus (DM), has recently gained attention for its cardiovascular benefits in diabetes via multiple cellular activities; however, whether liraglutide improves myocardial damage by inhibiting pyroptosis and the mechanisms of t...
Autores principales: | Zhang, Zhe, Wang, Xing, Yang, Linlin, Yang, Linquan, Ma, Huijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769506/ https://www.ncbi.nlm.nih.gov/pubmed/35096293 http://dx.doi.org/10.22038/IJBMS.2021.56771.12677 |
Ejemplares similares
-
Naringenin ameliorates homocysteine induced endothelial damage via the AMPKα/Sirt1 pathway
por: Li, Hui, et al.
Publicado: (2021) -
Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis‐related NLRP3 pathway
por: Song, Shuang, et al.
Publicado: (2022) -
Neuroprotective effect of liraglutide in an experimental mouse model of multiple sclerosis: role of AMPK/SIRT1 signaling and NLRP3 inflammasome
por: Ammar, Reham A., et al.
Publicado: (2022) -
Exogenous Hydrogen Sulfide Ameliorates Diabetic Myocardial Fibrosis by Inhibiting Cell Aging Through SIRT6/AMPK Autophagy
por: Li, Yaling, et al.
Publicado: (2020) -
SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury
por: Xin, Ting, et al.
Publicado: (2020)